Click here to load reader

Biopharmaceutical manufacturing: strategic outsourcing and

  • View
    0

  • Download
    0

Embed Size (px)

Text of Biopharmaceutical manufacturing: strategic outsourcing and

Microsoft PowerPoint - Slides AIDIC da inviarebusiness opportunities
Paolo Barbanti Biopharmaceutical manufacturing
NCE's launched per year
30
35
40
45
50
55
60
65
85 86 87 88 89 90 91 92 93 94 95 96 97 98 0
5
10
15
20
25
30
35
40
Paolo Barbanti Biopharmaceutical manufacturing
•patent expiry •time to market
•need new products •consolidation •cash rich
•provide innovation •need cash
Paolo Barbanti Biopharmaceutical manufacturing
Paolo Barbanti Biopharmaceutical manufacturing
Combinatorial Chemistry
Molecular Pharmacology
Molecular Biology
Paolo Barbanti Biopharmaceutical manufacturing
State Agencies
Paolo Barbanti Biopharmaceutical manufacturing
Shorter preclinical development time and lower cost for monoclonal antibodies
Paolo Barbanti Biopharmaceutical manufacturing
CNS 3%
ID 9%
Oncology 52%
AIID 22%
Respiratory 6%
CV 3%
Other 5%
Paolo Barbanti Biopharmaceutical manufacturing
Top 12 biotechnology countries